1. Home
  2. CORT vs COLB Comparison

CORT vs COLB Comparison

Compare CORT & COLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$113.79

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Logo Columbia Banking System Inc.

COLB

Columbia Banking System Inc.

HOLD

Current Price

$30.02

Market Cap

9.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
COLB
Founded
1998
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.2B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CORT
COLB
Price
$113.79
$30.02
Analyst Decision
Buy
Hold
Analyst Count
5
14
Target Price
$96.50
$31.46
AVG Volume (30 Days)
823.3K
2.6M
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
5.08%
EPS Growth
N/A
N/A
EPS
0.09
1.38
Revenue
$761,407,000.00
$177,000,000.00
Revenue This Year
$26.08
$31.52
Revenue Next Year
$26.98
$2.90
P/E Ratio
$1,224.56
$21.66
Revenue Growth
12.79
18.94
52 Week Low
$28.66
$23.83
52 Week High
$126.38
$33.68

Technical Indicators

Market Signals
Indicator
CORT
COLB
Relative Strength Index (RSI) 52.88 43.79
Support Level $108.25 $29.77
Resistance Level $124.30 $30.00
Average True Range (ATR) 5.29 0.67
MACD -0.76 0.02
Stochastic Oscillator 61.04 47.25

Price Performance

Historical Comparison
CORT
COLB

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About COLB Columbia Banking System Inc.

Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.

Share on Social Networks: